• TRADE NAMES: Amfipen; Ampicin; Binotal; D-Amp; Marcillin; Penbritin; Penstabil; Principen; Pro-Ampi; Sinaplin; Taro-Ampicillin Trihydrate; Totacillin (GSK); Totapen; Vidopen
  • INDICATIONS: Susceptible strains of gram-negative and gram-positive bacterial infections
  • CLASS: Antibiotic, Antibiotic; beta-lactam, Antibiotic; penicillin, Antimicrobial
  • HALF-LIFE: 1–1.5 hours

Five to 10% of people taking ampicillin develop eruptions between the 5th and 14th day following initiation of therapy. Also, there is a 95% incidence of exanthematous eruptions in patients who are treated for infectious mononucleosis with ampicillin. The allergenicity of ampicillin appears to be enhanced by allopurinol or by hyperuricemia. Ampicillin is clearly the more allergenic of the two drugs when given alone.

Used in combination with sulbactam (as Unasyn).

Please login to view the rest of this drug profile.

Page last updated 04/22/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric